Key result
Patients with Plateau Psycho-CVD exhibited significant upregulation of hsa-miR-1976 and hsa-miR-4685-3p, identifying them as novel biomarkers for plateau stress dual heart disease.
Why the study?
The study aimed to explore miRNA expression characteristics in cardiovascular diseases and depression within a plateau environment to understand their role in Plateau Psycho-CVD.
Observational (n=20)
Blinded analysis
No
hsa-miR-1976 and hsa-miR-4685-3p were identified as novel circulating biomarkers for Plateau Psycho-CVD, potentially linking cardiovascular and psychological stress responses via PI3K-Akt and neurotrophin pathways.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in plateau psycho-CVD; hypothesis-generating for miRNA roles in comorbid CVD and depression.
This study aimed to explore the expression characteristics of miRNAs in cardiovascular diseases (CVD) and depression within a plateau environment, to better understand their potential role in Plateau Psycho-CVD. A prospective study design was employed to analyze circulating small RNAs from 20 subjects using high-throughput sequencing technology. Participants were divided into four groups (C, PPC, PP, PC) for comparative analysis. Differentially expressed miRNAs were selected for further functional enrichment analysis. The findings revealed that hsa-miR-1976 and hsa-miR-4685-3p were significantly upregulated in patients with Plateau Psycho-CVD and mental health issues. These miRNAs were closely associated with key pathways relevant to cardiovascular and mental health, including the PI3K-Akt and neurotrophin signaling pathways. Additionally, the downregulated miRNAs in the PPC group were linked to increased expression of AKT1 and STAT3, genes associated with bipolar disorder and inflammatory pathways, indicating a potential impact on neural function. This study identifies hsa-miR-1976 and hsa-miR-4685-3p as novel biomarkers for plateau stress dual heart disease, with AKT1 and STAT3 emerging as potential therapeutic targets. These insights pave the way for further research and clinical applications in related fields.
No takes yet. Share an insight, caveat, or question.
Niu et al. (2025) conducted an observational in Plateau Psycho-CVD (n=20). Plateau Psycho-CVD vs. Plateau control group was evaluated on Differential expression of circulating miRNAs. Patients with Plateau Psycho-CVD exhibited significant upregulation of hsa-miR-1976 and hsa-miR-4685-3p, identifying them as novel biomarkers for plateau stress dual heart disease.
Synapse has enriched 10 related papers. Consider them for comparative context: